Healthcare provider profile · identity verified

Mario E Ruberte, MD

Internal Medicine · MELBOURNE, FL · NPI 1205857240

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	392	110
Levothyroxine Sodium	Levothyroxine Sodium	364	94
Amlodipine Besylate	Amlodipine Besylate	337	107
Losartan Potassium	Losartan Potassium	246	74
Alprazolam	Alprazolam	239	62
Rosuvastatin Calcium	Rosuvastatin Calcium	229	72
Gabapentin	Gabapentin	228	77
Lisinopril	Lisinopril	213	77
Omeprazole	Omeprazole	192	68
Metoprolol Succinate	Metoprolol Succinate	171	45
Pantoprazole Sodium	Pantoprazole Sodium	148	54
Metformin Hcl	Metformin Hcl	130	44
Zolpidem Tartrate	Zolpidem Tartrate	125	21
Tamsulosin Hcl	Tamsulosin Hcl	118	41
Valsartan	Valsartan	115	37
Metoprolol Tartrate	Metoprolol Tartrate	110	34
Ciprofloxacin Hcl	Ciprofloxacin Hcl	107	72
Sertraline Hcl	Sertraline Hcl	105	32
Hydrochlorothiazide	Hydrochlorothiazide	99	33
Montelukast Sodium	Montelukast Sodium	98	34
Simvastatin	Simvastatin	96	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	44
Carvedilol	Carvedilol	91	31
Ozempic	Semaglutide	89	21
Eliquis	Apixaban	86	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	82	23
Jardiance	Empagliflozin	80	21
Hydralazine Hcl	Hydralazine Hcl	78	19
Clonazepam	Clonazepam	77	15
Lovastatin	Lovastatin	76	18
Trazodone Hcl	Trazodone Hcl	75	22
Allopurinol	Allopurinol	71	25
Famotidine	Famotidine	68	28
Potassium Chloride	Potassium Chloride	68	22
Donepezil Hcl	Donepezil Hcl	66	18
Furosemide	Furosemide	64	25
Pioglitazone Hcl	Pioglitazone Hcl	60	16
Fluoxetine Hcl	Fluoxetine Hcl	59	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	18
Lorazepam	Lorazepam	58	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	18
Celecoxib	Celecoxib	56	12
Fluticasone Propionate	Fluticasone Propionate	55	35
Temazepam	Temazepam	55	14
Pravastatin Sodium	Pravastatin Sodium	54	18
Prednisone	Prednisone	54	23
Bupropion Xl	Bupropion Hcl	52	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	45
Azithromycin	Azithromycin	51	42
Doxycycline Hyclate	Doxycycline Hyclate	50	41
Escitalopram Oxalate	Escitalopram Oxalate	48	18
Duloxetine Hcl	Duloxetine Hcl	47	18
Clopidogrel	Clopidogrel Bisulfate	46	13
Spironolactone	Spironolactone	46	13
Quetiapine Fumarate	Quetiapine Fumarate	45	12
Glipizide Er	Glipizide	44	11
Memantine Hcl	Memantine Hcl	44	suppressed
Methocarbamol	Methocarbamol	43	17
Atenolol	Atenolol	39	12
Ezetimibe	Ezetimibe	38	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Tramadol Hcl	Tramadol Hcl	34	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	18
Meloxicam	Meloxicam	33	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Finasteride	Finasteride	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	13
Valacyclovir	Valacyclovir Hcl	30	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	11
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Vilazodone Hcl	Vilazodone Hcl	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Sotalol	Sotalol Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Fluconazole	Fluconazole	22	15
Labetalol Hcl	Labetalol Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	12
Fenofibrate	Fenofibrate	21	suppressed
Glipizide	Glipizide	21	suppressed
Methylprednisolone	Methylprednisolone	21	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Myrbetriq	Mirabegron	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Lactulose	Lactulose	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Livalo	Pitavastatin Calcium	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	12
Nitroglycerin	Nitroglycerin	16	suppressed
Nystatin	Nystatin	16	suppressed
Metronidazole	Metronidazole	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Amiloride Hcl	Amiloride Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Glimepiride	Glimepiride	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Linzess	Linaclotide	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error